CASEBIA Trademark

Trademark Overview

On Thursday, June 23, 2016, a trademark application was filed for CASEBIA with the United States Patent and Trademark Office. The USPTO has given the CASEBIA trademark a serial number of 87975695. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 5, 2024. This trademark is owned by Casebia Therapeutics Limited Liability Partnership. The CASEBIA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of human therapeutics using gene editing; pharmaceutical research and development services
casebia

General Information

Serial Number87975695
Word MarkCASEBIA
Filing DateThursday, June 23, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 5, 2024
Registration Number5298341
Registration DateTuesday, September 26, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2016

Trademark Statements

Goods and ServicesResearch and development of human therapeutics using gene editing; pharmaceutical research and development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 5, 2024
Primary Code042
First Use Anywhere DateWednesday, June 22, 2016
First Use In Commerce DateWednesday, June 22, 2016

Trademark Owner History

Party NameCasebia Therapeutics Limited Liability Partnership
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAscot, Berkshire SL57HL
GB
Party NameCasebia Therapeutics Limited Liability Partnership
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAscot, Berkshire SL57HL
GB
Party NameCasebia Therapeutics Limited Liability Partnership
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC4A3TW
GB

Trademark Events

Event DateEvent Description
Tuesday, October 4, 2016EXAMINERS AMENDMENT -WRITTEN
Monday, June 27, 2016NEW APPLICATION ENTERED
Wednesday, June 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 29, 2016ASSIGNED TO EXAMINER
Tuesday, October 4, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 4, 2016EXAMINERS AMENDMENT E-MAILED
Saturday, November 5, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 4, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, October 18, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, October 30, 2016ASSIGNED TO LIE
Wednesday, November 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 13, 2016PUBLISHED FOR OPPOSITION
Tuesday, December 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 10, 2017DIVISIONAL PROCESSING COMPLETE
Thursday, August 10, 2017STATEMENT OF USE PROCESSING COMPLETE
Monday, July 17, 2017SOU TEAS EXTENSION RECEIVED
Monday, July 17, 2017TEAS REQUEST TO DIVIDE RECEIVED
Monday, July 17, 2017TEAS STATEMENT OF USE RECEIVED
Monday, July 17, 2017SOU EXTENSION 1 FILED
Monday, July 17, 2017DIVISIONAL REQUEST RECEIVED
Monday, August 7, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 10, 2017SOU EXTENSION 1 GRANTED
Monday, July 17, 2017USE AMENDMENT FILED
Saturday, August 19, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 26, 2017REGISTERED-PRINCIPAL REGISTER
Monday, September 26, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 5, 2024CANCELLED SEC. 8 (6-YR)
Monday, April 9, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 18, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 9, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

casebia research development pharmaceutical services editing using human therapeutics gene